Protagonist Therapeutics (PTGX) Financials

$145.09

$-0.85 (-0.58%)

As on 09-Sep-2026 16:00EDT

Market cap

$9,429 Mln

Revenue (TTM)

$282 Mln

P/E Ratio

141.5

P/B Ratio

11.4

Div. Yield

0 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	281.99	46.02	434.43	60.00	26.58	27.36
Cost of Revenue	0.78	1.23	2.96	3.31	1.03	2.78
Gross Profit	281.59	44.79	434.43	60.00	26.58	27.36
Operating Expenses	223.24	202.92	181.59	153.65	157.95	153.20
Operating Profit (EBIT)	58.34	-158.13	252.84	-93.65	-131.37	-125.85
Other Income	--	--	--	--	3.98	0.29
Profit before Tax	84.34	-129.31	279.41	-78.96	-127.39	-125.55
Provision for Tax	1.43	0.84	4.22	-14.90	-3.98	-2.92
Profit after Tax (Net Income)	82.91	-130.15	275.19	-78.96	-123.41	-125.55
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-127.39	-125.55

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	841.54	614.71	675.30	336.68	215.61	300.02
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.82	9.74	22.03	0.22	1.14	3.66
Current Liabilities	37.18	45.44	47.40	21.27	31.18	44.02
Total Liabilities	922.73	669.89	744.73	357.95	247.93	347.70

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	78.40	92.32	153.08	2.37	4.85	6.96
Current Assets	807.15	577.57	591.64	355.58	243.08	340.74
Total Assets	922.73	669.89	744.73	357.95	247.93	347.70
Total Debt*	9.22	10.32	10.87	1.14	3.66	5.86
Net Current Assets	769.97	532.13	544.24	334.30	211.90	296.72

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	57.67	184.15	-70.24	-108.14	-107.87
Cash Flow from Investing Activities	--	-49.33	-299.48	-39.26	91.47	-15.86
Cash from Financing Activities	--	22.86	25.85	170.48	18.84	129.92
Net Cash Inflow / Outflow	--	--	--	--	2.17	6.20

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	1.03	-2.05	4.14	-1.28	-2.51	-2.61
Cash EPS ($)	--	-2.03	4.19	-1.22	-2.44	-2.55
Adjusted Book Value ($)	--	9.67	10.17	5.45	4.38	6.23
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.91	2.77	-1.14	-2.20	-2.24
Free Cash Flow per Share ($)	--	0.88	2.75	-1.15	-2.21	-2.26

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	-19.85	53.75	-28.35	-47.00	-42.46
ROE (%)	11.39	-20.18	54.39	-28.59	-47.87	-43.32
ROA (%)	9.89	-18.40	49.91	-26.06	-41.44	-37.36
EBIT Margin (%)	-28.64	-281.01	64.32	-131.59	-494.24	-458.94
Net Margin (%)	29.40	-282.83	63.34	-131.59	-403.83	-454.06
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	34.81	-0.89	6.24	1.26	-0.03	-0.04
EBIT Growth (%)	-250.20	-146.28	453.88	39.90	-4.64	-94.60
Net Profit Growth (%)	59.32	-147.29	448.54	36.02	1.70	-89.80
EPS Growth (%)	44.83	-1.49	4.24	0.49	0.04	-0.56
Book Value Growth (%)	12.68	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	141.48	-42.66	9.31	-17.95	-4.35	-13.12
Price / Book Value	11.45	9.03	3.80	4.21	2.49	5.49
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	147.96	-39.00	7.69	-14.23	-2.37	-10.80
Close Price ($)	122.58	87.34	38.60	22.93	10.91	34.20
High Price ($)	126.59	96.54	48.89	30.10	37.05	50.54
Low Price ($)	49.38	33.70	21.43	10.57	6.91	12.80
Market Cap ($ Cr)	9,429.29	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	--	0.02	0.02	0.00	0.02	0.02
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.01	0.01
Current Ratio	21.71	12.71	12.48	16.71	7.80	7.74
Quick Ratio	21.71	--	--	17.20	7.80	7.55
Interest Coverage	--	--	--	--	-38.99	-50.60

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	4.76	9.77	38.78	17.22	0.20	19.49
Asset Turnover	0.34	0.07	0.79	0.20	0.09	0.08
Receivable days	--	686.53	75.17	31.61	37.00	61.11
Inventory Days	--	--	-1,273.63	-574.89	1,488.08	821.25
Payable days	--	1,036.71	147.12	243.28	927.28	307.67
Cash Conversion Cycle	--	--	-1,345.58	-786.57	597.79	574.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)